Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
The sub-therapeutic starting dose exists for a reason
Novo Nordisk reported the results from the STEP 1 extension trial on the impact of treatment withdrawal, which found that one year after withdrawal of once-weekly subcutaneous semaglutide 2.4 mg and lifestyle intervention, participants regained two-thirds of their prior weight loss
Retatrutide is a new weight management drug injected weekly just under the skin (subcutaneous)
2017;13(1):91-98.[DOI] 85
Current Pharmaceutical Design (2011) 6
US$ 24.65
US$ 24.69
US$ 29.97
US$ 27.90
